(Boston Children's Hospital) Children needing a bone marrow transplant often lack a fully matched donor and face a risk of acute, life-threatening graft-versus-host disease (GVHD). Now there's reason to hope: An arthritis drug that also can prevent GvHD is getting closer to FDA approval.
Original Article: A big step toward curbing graft-vs.-host disease after bone marrow transplant
NEXT ARTICLEQuick Links
Advanced Search |
Login |
Subscribe |
RSS